Elanco Animal Health ELAN
NYSE ELAN
$23.81 -0.16 (-0.67%)
As of: Sep 9, 2026 · 2:30 PM EDT

Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2026)

Elanco Animal Health's (ELAN) quarterly Non-Current Debt came in at $3.8 billion in Q2 2026, down 7.3% year-over-year from $4.1 billion in Q2 2025, and down 1.86% quarter-over-quarter from $3.9 billion in Q1 2026.

Analysis

Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2026) Analysis & Trends

Elanco Animal Health has disclosed Non-Current Debt across 9 years of filings, most recently posting $3.8 billion for Q2 2026.

  • In Q2 2026, Non-Current Debt fell 7.3% year-over-year to $3.8 billion; the TTM figure through Jun 2026 stood at $3.8 billion (down 7.3% YoY), while the FY2025 annual figure was $3.9 billion, down 8.75% from the prior year.
  • Non-Current Debt came in at $3.8 billion for Q2 2026 at Elanco Animal Health, down from $3.9 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $6.1 billion in Q1 2022 to a low of $3.8 billion in Q2 2026.
  • Average Non-Current Debt over 5 years is $5.0 billion, with a median of $5.1 billion recorded in 2024.
  • Year-over-year, Non-Current Debt climbed 0.14% in 2023 and dropped 28.72% in 2024.
  • Over 5 years, Non-Current Debt stood at $5.8 billion in 2022, then slipped by 1.06% to $5.8 billion in 2023, then fell by 25.16% to $4.3 billion in 2024, then dropped by 8.75% to $3.9 billion in 2025, then declined by 2.49% to $3.8 billion in 2026.
  • Per Business Quant data, the three most recent Non-Current Debt figures were $3.8 billion in Q2 2026, $3.9 billion in Q1 2026, and $3.9 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Idexx Laboratories 40.52 Bn 40.33 Bn 779.09 Mn 299.87 Mn
2 Zoetis 30.69 Bn 29.02 Bn 1.05 Bn 9.05 Bn
3 Elanco Animal Health 11.89 Bn 11.36 Bn 798.00 Mn 3.85 Bn
4 Phibro Animal Health 1.50 Bn 1.42 Bn 134.40 Mn 591.77 Mn
5 Immucell 89.92 Mn 81.06 Mn 2.44 Mn 8.30 Mn
6 Zhengye Biotechnology Holding 75.05 Mn 67.96 Mn - 1.25 Mn
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.85 Bn
Mar 31, 2026 3.92 Bn
Dec 31, 2025 3.94 Bn
Sep 30, 2025 3.96 Bn
Jun 30, 2025 4.15 Bn
Mar 31, 2025 4.40 Bn
Dec 31, 2024 4.32 Bn
Sep 30, 2024 4.36 Bn
Jun 30, 2024 4.32 Bn
Mar 31, 2024 5.77 Bn
Dec 31, 2023 5.77 Bn
Sep 30, 2023 5.91 Bn
Jun 30, 2023 6.06 Bn
Mar 31, 2023 6.02 Bn
Dec 31, 2022 5.84 Bn
Sep 30, 2022 5.90 Bn
Jun 30, 2022 6.06 Bn
Mar 31, 2022 6.13 Bn
Dec 31, 2021 6.32 Bn
Sep 30, 2021 6.33 Bn